AVY three-lens brief
Evidence-based stock research on AVY. Three independent lenses — Quality, Momentum, Context — examine live data from SEC filings, the Federal Reserve, and market feeds. Every claim traces to its primary source.
Underperforming SPY by 20.4pp over 30 days. · Trading at 10% of its 52-week range — deep in the lower band.
- Trading at 10% of its 52-week range — deep in the lower band.
- Underperforming SPY by 20.4pp over 30 days.
- Analyst mean target $200.30 — 25% above current (10 analysts).
- Debt-to-equity of 164.8 — balance-sheet-heavy.
AVY closed at $160.50 (+0.24%) as of 2026-05-13. Market cap: $12.28B. P/E (trailing) 18.1. Positives: analyst mean target $200.30 — 25% above current (10 analysts).. Concerns: trading at 10% of its 52-week range — deep in the lower band.; underperforming SPY by 20.4pp over 30 days.. Last quarter: Revenue $2.30B, net income $168.10M, free cash flow $809.05M.
Why three lenses on AVY, not one.
A single reasoning model has blind spots it doesn’t know about. We examine AVYacross Quality (fundamentals), Momentum (price action and sentiment), and Context (macro/sector). Disagreement between lenses is surfaced, not hidden — it’s how you know when HOLD is the honest call.
Read the full methodologyDrop it in your newsletter or blog.
Free to embed. Updates every 6 hours. Links back to the full brief.
<iframe src="https://clearpathinvest.app/embed/AVY" width="100%" height="420" frameborder="0" loading="lazy" title="ClearPath AVY brief"></iframe>